Biotech

All Articles

Boundless Biography produces 'modest' cutbacks 5 months after $100M IPO

.Simply five months after protecting a $one hundred thousand IPO, Limitless Biography is actually cu...

Halda's $126M will accelerate 'keep and get rid of' growth medications

.The initial stages of oncology R&ampD aren't except interesting brand-new modalities, and also Hald...

Lykos 'regrets' certainly not making known research study violations with author

.Psychopharmacology has actually taken three short articles regarding midstage medical trial informa...

Analysts dig into Avidity's DMD succeed, showing nuances in information

.Avidity Biosciences amazed clients with period 1/2 information in Duchenne muscular dystrophy (DMD)...

Actinogen's cortisol blocker falls short stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has overlooked the major endpoint of a stage 2 study in clinic...

Bivictrix determines going exclusive only method to take ADC right into center

.Antibody-drug conjugates (ADCs) have been at the facility of numerous a billion-dollar biobuck lice...

TPG tops up funds to $580M for assets around life scientific researches

.Resource manager TPG, which has actually assisted biotechs like Sionna Therapeutics and also Santa ...

Merck quits stage 3 TIGIT test in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT course has actually endured yet another problem. Months after shuttering a p...

After a challenging year, Exscientia folds in to Recursion

.After a year defined through pipeline hairstyles, the shift of its own CEO and cutbacks, Exscientia...

Cullinan, after $25M offer, restore bispecific to Harbour

.Cullinan Therapy was actually excited good enough along with Harbour BioMed's bispecific immune act...